Overview

Phase 3 Herniorrhaphy for Postoperative Pain

Status:
Recruiting
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
Subjects receive either CPL-01, positive control, or negative control after herniorrhaphy and are then followed.
Phase:
Phase 3
Details
Lead Sponsor:
Cali Pharmaceuticals LLC
Treatments:
Anesthetics
Anesthetics, Local